This federal contract award, valued at $4,951.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Fluticasone-Salmeterol 230-21 12GM, a medical product used in respiratory healthcare. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's significant role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical supplies, to the Department of Defense and other federal healthcare programs.
Generated 3/6/25, 10:02 AM